<code id='B1ED0029A0'></code><style id='B1ED0029A0'></style>
    • <acronym id='B1ED0029A0'></acronym>
      <center id='B1ED0029A0'><center id='B1ED0029A0'><tfoot id='B1ED0029A0'></tfoot></center><abbr id='B1ED0029A0'><dir id='B1ED0029A0'><tfoot id='B1ED0029A0'></tfoot><noframes id='B1ED0029A0'>

    • <optgroup id='B1ED0029A0'><strike id='B1ED0029A0'><sup id='B1ED0029A0'></sup></strike><code id='B1ED0029A0'></code></optgroup>
        1. <b id='B1ED0029A0'><label id='B1ED0029A0'><select id='B1ED0029A0'><dt id='B1ED0029A0'><span id='B1ED0029A0'></span></dt></select></label></b><u id='B1ED0029A0'></u>
          <i id='B1ED0029A0'><strike id='B1ED0029A0'><tt id='B1ED0029A0'><pre id='B1ED0029A0'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:knowledge    Page View:1
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          New details revealed about Purdue's marketing of OxyContin
          New details revealed about Purdue's marketing of OxyContin

          MassachusettsAttorneyGeneralMauraHealeyJessicaRinaldi/TheBostonGlobeWhenPurduePharmastartedsellingit

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          Asahi Kasei to buy Calliditas, picking up kidney disease drug

          AdobeLONDON—Seekingtobuildupitspharmabusiness,theJapaneseconglomerateAsahiKaseiismovingtobuySwedishb